SEARCH THE OnBioVC DATABASE:
OnBioVC NEWS:

- OnBioVC 4Q11 Trend Analysis, now available
- OnBioVC 1Q12 Trend Analysis, coming soon

26

Jan

2012

PolyTherics, Ltd.: Series C $3.5M

Posted in I - Series C, Q - 3Q11, R - INTERNATIONAL, X - Biochem, X - GlycoBiology

PolyTherics (United Kingdom) a preclinical-stage biochemistry company focused on pegylation technologies, closed a $3.5M Series C financing. Participants include Beringea, Imperial Innovation and The Capital Fund.

Thanx for your patience as we catch-up.

Venture Capital Investors
5AM Ventures Advanced Technology Ventures Alta Partners Amgen Ventures ARCH Venture Partners Bay City Capital Bessemer Venture Partners Canaan Partners Clarus Ventures Delphi Ventures Domain Associates Edmond de Rothschild Investment Partners Excel Venture Management Flagship Ventures Forbion Capital Partners HBM Bioventures Healthcare Ventures HLM Venture Partners Interwest Partners Investor Growth Capital Kleiner Perkins Latterell Venture Partners Lilly Ventures Mohr Davidow Ventures MPM Capital New Enterprise Associates New Leaf Venture Partners Novartis Venture Fund Novo Ventures OrbiMed Pappas Ventures Polaris Venture Partners Prospect Venture Partners Quaker BioVentures Sanderling Ventures Sofinnova Partners Sofinnova Ventures SR One SV Life Sciences Third Rock Ventures TPG Biotech TVM Capital U.S. Venture Partners Venrock Versant Ventures

OnBioVC Friends

FluidicMEMES
IguanaBio
EyeOnFDA
Patent Baristas
Pharma's Cutting Edge
MedTechIQ
The Antibody Blog
BioJobBlog

OnBioVC Partners